X-ChemRx operates in the pharmaceutical and biotechnology sector, specializing in the discovery and development of small molecule drugs. The company leverages its proprietary ArtemisAI platform, which utilizes a suite of machine learning models and extensive DNA-encoded chemical library (DEL) data to accelerate the drug discovery process. X-ChemRx serves pharmaceutical companies, biotech firms, and academic institutions, providing them with advanced tools to identify and develop new drug candidates more efficiently. The business model revolves around offering drug discovery services and licensing its technology to clients, generating revenue through service fees and licensing agreements. By integrating AI and machine learning, X-ChemRx aims to revolutionize the way new medicines are discovered, making the process faster and more effective.

Keywords: AI-powered, drug discovery, small molecules, ArtemisAI, machine learning, DEL data, pharmaceutical, biotechnology, drug development, licensing.